These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 22358155)
1. Pill burden in HIV infection: 20 years of experience. Krentz HB; Cosman I; Lee K; Ming JM; Gill MJ Antivir Ther; 2012; 17(5):833-40. PubMed ID: 22358155 [TBL] [Abstract][Full Text] [Related]
2. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. Ma A; Chen DM; Chau FM; Saberi P AIDS Care; 2010 Oct; 22(10):1189-94. PubMed ID: 20640958 [TBL] [Abstract][Full Text] [Related]
3. Actual medication pill burden and dosing frequency in HIV-infected patients with undetectable viral loads. Clay PG J Int Assoc Physicians AIDS Care (Chic); 2004; 3(2):49-55. PubMed ID: 15346690 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Garvie PA; Lensing S; Rai SN Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa. Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857 [TBL] [Abstract][Full Text] [Related]
6. Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients. Winters MA; Chary A; Eison R; Asmuth D; Holodniy M J Med Virol; 2010 May; 82(5):791-8. PubMed ID: 20336744 [TBL] [Abstract][Full Text] [Related]
7. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of antiretroviral treatment in two private medical centers in Addis, Ethiopia. Habtegiorgis A; Gebreyesus S; Mulugeta E Ethiop Med J; 2003 Oct; 41(4):345-51. PubMed ID: 15296416 [TBL] [Abstract][Full Text] [Related]
9. Identification of potential drug-drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South Africa. Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I Int J STD AIDS; 2012 Mar; 23(3):166-72. PubMed ID: 22581868 [TBL] [Abstract][Full Text] [Related]
11. Impact of three decades of antiretroviral therapy in a longitudinal population cohort study. Hanhoff N; Vu Q; Lang R; Gill MJ Antivir Ther; 2019; 24(3):153-165. PubMed ID: 30614788 [TBL] [Abstract][Full Text] [Related]
12. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care. Herrmann S; McKinnon E; John M; Hyland N; Martinez OP; Cain A; Turner K; Coombs A; Manolikos C; Mallal S Intern Med J; 2008 Jan; 38(1):8-15. PubMed ID: 17916167 [TBL] [Abstract][Full Text] [Related]
13. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country. Kouanda S; Bocoum FY; Doulougou B; Bila B; Yameogo M; Sanou MJ; Sawadogo M; Sondo B; Msellati P; Desclaux A AIDS Care; 2010 Sep; 22(9):1146-52. PubMed ID: 20824567 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study. Blick G; Greiger-Zanlungo P; Gretz S; Han J; Dupree D; Garton T; Yau LH; Wine BC; Pakes GE; Int J STD AIDS; 2012 Mar; 23(3):e18-22. PubMed ID: 22581890 [TBL] [Abstract][Full Text] [Related]
15. [Impact of antiretroviral therapy in mortality of Chilean HIV (+) patients: a case control study]. Wolff M; Bustamante C; Bidart T; Dabanch J; Diomedi A; Northland R Rev Med Chil; 2000 Aug; 128(8):839-45. PubMed ID: 11129544 [TBL] [Abstract][Full Text] [Related]
16. Antiretroviral drug adherence by HIV infected children attending Kericho District Hospital, Kenya. Langat NT; Odero W; Gatongi P East Afr J Public Health; 2012 Sep; 9(3):101-4. PubMed ID: 23136705 [TBL] [Abstract][Full Text] [Related]
17. Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France. Allavena C; Jacomet C; Pereira B; Morand-Joubert L; Bagheri H; Cotte L; Garaffo R; Gerbaud L; Dellamonica P J Int AIDS Soc; 2014; 17(4 Suppl 3):19608. PubMed ID: 25394112 [TBL] [Abstract][Full Text] [Related]
18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
19. Total daily pill burden in HIV-infected patients in the southern United States. Zhou S; Martin K; Corbett A; Napravnik S; Eron J; Zhu Y; Casciere B; Boulton C; Loy B; Smith S; Woods A; Murray M; Ramsdell L; Wohl DA AIDS Patient Care STDS; 2014 Jun; 28(6):311-7. PubMed ID: 24901464 [TBL] [Abstract][Full Text] [Related]
20. Once-a-day therapy for HIV infection: a controlled, randomized study in antiretroviral-naive HIV-1-infected patients. Maggiolo F; Ripamonti D; Gregis G; Quinzan G; Callegaro A; Arici C; Ravasio L; Suter F Antivir Ther; 2003 Aug; 8(4):339-46. PubMed ID: 14518703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]